Valsartan suppresses cardiovascular events in hypertensive subjects with diabetes mellitus (DM) comparable to those with impaired glucose tolerance (IGT)

被引：0
|
作者：
Kondo, T. [1 ]
Yamashita, K. [1 ]
Muramatsu, T. [1 ]
Matsushita, K. [1 ]
Nagahiro, T. [1 ]
Maeda, K. [1 ]
Shintani, S. [1 ]
Murohara, T. [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：679 / 680
页数：2
相关论文
共 50 条
  • [41] CARDIOVASCULAR RISK-FACTORS IN SUBJECTS WITH DIABETES, IMPAIRED GLUCOSE-TOLERANCE AND NORMAL - A POPULATION STUDY
    LAZZARI, P
    BOARI, L
    DIABETOLOGIA, 1994, 37 : A201 - A201
  • [42] Insulin secretion in subjects genetically predisposed to T2DM and impaired glucose tolerance (IGT) is readily susceptible to FFA-induced lipotoxicity
    Mathew, Manoj
    Kumar, Pratima
    Ali, Rafeeq
    Wang, Shaoyun
    Cusi, Kenneth
    DIABETES, 2008, 57 : A46 - A46
  • [43] Xenin-25 (Xen) Delays Gastric Emptying and Reduces Postprandial Glucose Levels in Humans With Normal (NGT) or Impaired Glucose Tolerance (IGT) and Type 2 Diabetes Mellitus (T2DM)
    Chowdhury, Sara
    Reeds, Dominic N.
    Wang, Songyan
    Tran, Hung D.
    Dunai, Judit
    Rometo, David
    Laciny, Erin
    Patterson, Bruce W.
    Polonsky, Kenneth S.
    Wice, Burton M.
    DIABETES, 2012, 61 : A481 - A481
  • [44] Conventional and Novel Risk Factors for Fatal and Non-Fatal Cardiovascular Events in 9306 Subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
    Califf, Robert M.
    Giles, Thomas
    Haffner, Steven M.
    Holman, Rury R.
    Laakso, Markku
    Martinez, Felipe
    Mazzone, Theodore
    Pieper, Karen S.
    Rutten, Guy E. H. M.
    Standl, Eberhard
    Thomas, Laine
    Tognoni, Gianni
    Mcmurray, John J. V.
    DIABETES, 2011, 60 : A362 - A362
  • [45] PREVENTION OF DIABETES AND REDUCTION IN MAJOR CARDIOVASCULAR EVENTS IN STUDIES OF SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE: META-ANALYSIS OF RANDOMIZED CONTROLLED CLINICAL TRIALS
    Hopper, Ingrid
    Billah, Baki
    Skiba, Marina
    Krum, Henry
    HYPERTENSION, 2011, 58 (01) : 126 - 126
  • [46] Prevention of Diabetes and Reduction in Major Cardiovascular Events in Studies of Subjects with Impaired Glucose Tolerance: Meta-analysis of Randomized Controlled Clinical Trials
    Hopper, Ingrid K.
    Billah, Baki
    Skiba, Marina A.
    Krum, Henry
    CIRCULATION, 2010, 122 (21)
  • [47] PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) ACTIVITY IS RAISED IN SUBJECTS WITH NIDDM BUT NOT IN THOSE WITH IMPAIRED GLUCOSE-TOLERANCE (IGT) OR SOUTH ASIANS
    NAGI, D
    YUDKIN, J
    DIABETES, 1995, 44 : A227 - A227
  • [48] Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study:: Results from a randomized clinical trial
    Lindström, J
    Eriksson, JG
    Valle, TT
    Aunola, S
    Cepaitis, Z
    Hakumäki, M
    Hämäläinen, H
    Ilanne-Parikka, P
    Keinänen-Kiukaanniemi, S
    Laakso, M
    Louheranta, A
    Mannelin, M
    Martikkala, V
    Moltchanov, V
    Rastas, M
    Salminen, V
    Sundvall, J
    Uusitupa, M
    Tuomilehto, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : S108 - S113
  • [49] Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance - The Australian diabetes, obesity, and lifestyle study (AusDiab)
    Barr, Elizabeth L. M.
    Zimmet, Paul Z.
    Welborn, Timothy A.
    Jolley, Damien
    Magliano, Dianna J.
    Dunstan, David W.
    Cameron, Adrian J.
    Dwyer, Terry
    Taylor, Hugh R.
    Tonkin, Andrew M.
    Wong, Tien Y.
    McNeil, John
    Shaw, Jonathan E.
    CIRCULATION, 2007, 116 (02) : 151 - 157
  • [50] The glucose tolerance test, but not HbA1c, remains the gold standard in identifying impaired glucose tolerance and diabetes mellitus in subjects with systemic hypertension
    Salmasi, A. M.
    Dancy, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 496 - 497
12345